Intravenous solutions are sterile solutions administered intravenously into the body for hydration and replenishing electrolytes. They aid in correcting electrolyte imbalances and maintain fluid balance. The growing aging population and rising incidence of chronic diseases have increased the demand for intravenous solutions. Moreover, the expanding healthcare infrastructure in developing nations has facilitated greater access to intravenous therapy.

The global Intravenous Solutions Market is estimated to be valued at US$ 577228 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
One of the major trends driving the growth of the intravenous solutions market is the expansion of healthcare infrastructure across the globe. Several developing nations are investing heavily in developing and upgrading their healthcare facilities. For instance, the Indian government launched the Ayushman Bharat initiative that aims to set up 1.5 lakh health and wellness centers across India by 2022. Moreover, China is also working towards developing county-level hospitals with ICU facilities in all regions by 2020. This rising accessibility to healthcare services has increased the adoption of intravenous solutions for hydration and replenishing electrolytes. The expanding healthcare infrastructure in developing countries has created significant opportunities for players in the intravenous solutions market.

Segment Analysis
The global intravenous solutions market is segmented by type and end user. Based on type, the market is segmented into crystalloids, colloids, and others. Crystalloids is dominating the market and accounts for over 60% market share due to high usage in general fluid management. Crystalloids are used to manage fluid balance, electrolyte balance, and acid-base balance.


Porter's Analysis
Threat of new entrants: The threat of new entrants is moderate as the intravenous solutions market requires high capital investment and manufacturing infrastructure to produce sterile intravenous solutions.

Bargaining power of buyers: The bargaining power of buyers is high as the intravenous solutions market has several leading players providing similar product offerings to customers. Buyers can negotiate on price points.

Bargaining power of suppliers: The bargaining power of suppliers is moderate as the raw material suppliers for intravenous solutions have established distribution channels but suppliers still depend on key manufacturers for offtake of materials.

Threat of new substitutes: The threat of new substitutes is low as intravenous therapy offers direct delivery of drugs, nutrients, and fluids into the bloodstream with minimal risk of infection, making it difficult to substitute.

Competitive rivalry: The competitive rivalry is high due to the presence of numerous established brands offering generic and branded intravenous solutions.

SWOT Analysis
Strengths: The intravenous solutions market has strong growth potential driven by rising prevalence of chronic diseases, surge in surgical procedures, and growing geriatric population globally requiring intravenous therapy.

Weaknesses: High manufacturing and operational costs associated with sterile and aseptic production of intravenous solutions. Short shelf life of some solutions limits their applications.

Opportunities: Untapped growth prospects in emerging nations present lucrative opportunities. Expanding therapeutic areas like oncology and infectious diseases will drive the demand for novel intravenous drugs and solutions.

Threats: Stringent regulatory frameworks and product approval challenges add to compliance burden. Supply chain disruptions and unpredictability of raw material prices are possible threats.

Key Takeaways
The Global Intravenous Solutions Market Size is expected to witness high growth driven by rising prevalence of chronic diseases, aging population, and increasing healthcare spending. The market size is projected to reach US$ 577228 Mn by 2023 from US$ 421000 Mn in 2018, representing a CAGR of 10.% during the forecast period.

Regional analysis
Asia Pacific region is expected to grow at the fastest pace owing to large patient pools, rising healthcare standards, and increasing medical tourism. China and India are emerging as dominant markets in the region. North America currently dominates the intravenous solutions market owing to well-established healthcare infrastructure and high adoption of advanced therapies.

Key players
Key players operating in the intravenous solutions market are Amara Halal Cosmetics, Andalou,Clara International Beauty Group, COSMECCA KOREA, COSRX, Ecotrail Personal Care Pvt. Ltd., Halal Korea Co., Ltd., INGLOT Cosmetics, INIKA organic, IVY Beauty Corporation, KOLMAR KOREA, SO.LEK Cosmetics, and Talent Cosmetics

 

Get more insights on this topic:
https://www.writerscafe.org/naufancmi/blogs/The-global-Intravenous-Solutions-Market-Growth-Accelerated-by-Expansion-of-Healthcare-Infrastructure-/212687/